163 related articles for article (PubMed ID: 4120338)
21. Oral medications for minimal brain dysfunction in children.
Green RP; Scales SM; Rosser PL
J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
[No Abstract] [Full Text] [Related]
22. [Minimal brain dysfunction--what does it imply in child development and adaptation].
Hagberg B
Lakartidningen; 1975 Sep; 72(36):3296-300. PubMed ID: 51954
[No Abstract] [Full Text] [Related]
23. [Focus on conceptual evolution of the etiology of motor skill disorders].
Dopchie N
Brux Med; 1978 Jun; 58(6):311-3. PubMed ID: 78750
[No Abstract] [Full Text] [Related]
24. A critical note on the predictive validity of "the hyperkinetic syndrome".
Shaffer D; Greenhill L
J Child Psychol Psychiatry; 1979 Jan; 20(1):61-72. PubMed ID: 422687
[No Abstract] [Full Text] [Related]
25. Organic factors in hyperkinesis: a critical evaluation.
Dubey DR
Am J Orthopsychiatry; 1976 Apr; 46(2):353-66. PubMed ID: 773196
[TBL] [Abstract][Full Text] [Related]
26. Behavioral problems of the child with minimal cerebral dysfunction.
Mordock JB
Phys Ther; 1971 Apr; 51(4):398-404. PubMed ID: 5549147
[No Abstract] [Full Text] [Related]
27. Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
Wender PH
Ann N Y Acad Sci; 1973 Feb; 205():18-28. PubMed ID: 4570233
[No Abstract] [Full Text] [Related]
28. Minimal brain dysfunction.
Leary PM
S Afr Med J; 1976 May; 50(20):784-6. PubMed ID: 935955
[TBL] [Abstract][Full Text] [Related]
29. Recognizing minimal cerebral dysfunction in the infant and toddler. Some clinical clues and thoughts on management.
Nichamin SJ
Clin Pediatr (Phila); 1972 May; 11(5):255-7. PubMed ID: 5028568
[No Abstract] [Full Text] [Related]
30. Bone age in children with minimal brain dysfunction.
Schlager G; Newman DE; Dunn HG; Crichton JU; Schulzer M
Dev Med Child Neurol; 1979 Feb; 21(1):41-51. PubMed ID: 220126
[No Abstract] [Full Text] [Related]
31. Early development of infants of heroin-addicted mothers.
Wilson GS; Desmond MM; Verniaud WM
Am J Dis Child; 1973 Oct; 126(4):457-62. PubMed ID: 4131562
[No Abstract] [Full Text] [Related]
32. Clinical experience with methylphenidate.
Leary PM; Arens L; Marshall S; Schadle S
S Afr Med J; 1979 Mar; 55(10):374-6. PubMed ID: 432732
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of children referred because of hyperactivity.
Kenny TJ; Clemmens RL; Hudson BW; Lentz GA; Cicci R; Nair P
J Pediatr; 1971 Oct; 79(4):618-22. PubMed ID: 5094256
[No Abstract] [Full Text] [Related]
34. [Undetected minimal cerebral dysfunction in educationally difficult children].
Rautenstrauch T; Wittrock J
Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):629-30. PubMed ID: 4411397
[No Abstract] [Full Text] [Related]
35. Hyperactivity in children: types, diagosis, drug therapy, approaches to management.
Howell MC; Rever GW; Scholl ML; Trowbridge F; Rutledge A
Clin Pediatr (Phila); 1972 Jan; 11(1):30-9. PubMed ID: 5061326
[No Abstract] [Full Text] [Related]
36. Drugs in management of minimal brain dysfunction.
Millichap JG
Ann N Y Acad Sci; 1973 Feb; 205():321-34. PubMed ID: 4144050
[No Abstract] [Full Text] [Related]
37. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
Gross MD
Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
[No Abstract] [Full Text] [Related]
38. [Minimal brain dysfunction in the young child].
Güldenpfernig WM
SA Nurs J; 1974 Aug; 41(8):21-2. PubMed ID: 4139770
[No Abstract] [Full Text] [Related]
39. Minimal brain dysfunction as a neurodevelopmental lag.
Kinsbourne M
Ann N Y Acad Sci; 1973 Feb; 205():268-73. PubMed ID: 4120340
[No Abstract] [Full Text] [Related]
40. Using cerebral stimulants to treat minimal brain dysfunction.
Loney J; Ordoña TT
Am J Orthopsychiatry; 1975 Jul; 45(4):564-572. PubMed ID: 1180339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
